About Allelica
Allelica is a company based in Rome (Italy) founded in 2017 by Giordano Botta, Paolo Di Domenico, and George Busby. Allelica has raised $1.81 million across 3 funding rounds from investors including EIT Health, Valor Ventures and Pi Campus. Allelica offers products and services including Clinical PRS Test, Allelica Precision Server, and Corporate Health Resources. Allelica operates in a competitive market with competitors including Tessera Therapeutics, Phase Genomics, SeqOne, Hexagon Bio and Cellanome, among others.
- Headquarter Rome, Italy
- Founders Giordano Botta, Paolo Di Domenico, George Busby
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Allelica, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.81 M (USD)
in 3 rounds
-
Latest Funding Round
$1.75 M (USD), Seed
Mar 11, 2021
-
Investors
EIT Health
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Allelica
Allelica offers a comprehensive portfolio of products and services, including Clinical PRS Test, Allelica Precision Server, and Corporate Health Resources.
Assesses polygenic risk for diseases to inform preventive care
Enables in-house genetic analysis and reporting for labs
Supports workplace genetic risk programs for employee health
People of Allelica
Unlock access to complete
Unlock access to complete
Advisor Team
7 people
Sales and Marketing
2 people
Leadership Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of Allelica
Allelica has successfully raised a total of $1.81M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $1.75 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Allelica
Allelica has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include EIT Health, Valor Ventures and Pi Campus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided by Valor Ventures for seed-stage startups.
|
Locked | Locked | Locked | |
|
Early-stage AI startups are funded and supported by Pi Campus.
|
Locked | Locked | Locked | |
|
Healthcare startups are accelerated and incubated through specialized programs.
|
Locked | Locked | Locked |
Investor details for Allelica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Allelica
Investment portfolio details for Allelica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Allelica
Detailed financials for Allelica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Allelica Comparisons
Peer comparison for Allelica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Allelica
Allelica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tessera Therapeutics, Phase Genomics, SeqOne, Hexagon Bio and Cellanome, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
New genome engineering technology is provided for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Laboratory and computational services for DNA proximity analysis are provided.
|
|
| Locked | Locked | Locked |
Bioinformatics tools for genome sequencing data analysis are provided.
|
|
| Locked | Locked | Locked |
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
|
|
| Locked | Locked | Locked |
Developer of the omic data platform for researchers
|
|
| Locked | Locked | Locked |
Sequencing technology is developed for microbiome testing and pathogen identification.
|
Detailed competitors of Allelica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Allelica
Complete news archive for Allelica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Allelica
Allelica was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Allelica is headquartered in Rome, Italy. It is registered at Rome, Lazio, Italy.
Giordano Botta is the current CEO of Allelica. They have also founded this company.
Allelica is a funded company, having raised a total of $1.81M across 3 funding rounds to date.
Allelica was founded in 2017 in Rome, Italy, and operates in the genomics sector. DNA test kits based on swab-based saliva sampling are provided, along with online reports and nutritional plans for assessing disease predisposition and personalized nutrition. A platform for the COVID-19 HG Initiative has been developed to collect clinical data from hospitalized patients. Polygenic risk scores are computed using genetic variants.
Allelica's top competitors include Tessera Therapeutics, Phase Genomics and SeqOne.
Allelica offers Clinical PRS Test, Allelica Precision Server, and Corporate Health Resources.
Allelica has 4 investors. Key investors include EIT Health, Valor Ventures, Pi Campus, and MGZ - Medical Genetics Center.